TYSABRI® RISK MINIMIZATION ACTION PLAN: SUMMARY OF TOUCHSM

First Page		Document Content
Natalizumab Biogen Idec Pharmacology Medical prescription Progressive multifocal leukoencephalopathy Medicine Health Immunosuppressants		TYSABRI® RISK MINIMIZATION ACTION PLAN: SUMMARY OF TOUCHSM Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 54,89 KB Share Document on Facebook

	www.edoriumjournals.com CASE REPORT PEER REVIEWED \| OPEN ACCESS DocID: 1qwuZ - View Document
	2 Research news PML case reported for dimethyl fumarate (Tecfidera) A case of progressive multifocal leukoencephalopathy (PML) has been reported in a person who had been taking dimethyl fumarate. The person, who subsequ DocID: 1bzBm - View Document
	by Nancy Wongvipat, M.P.H. he first HAART treatments, in 1996, included a protease inhibitor along with two nucleoside analog drugs to DocID: 1aYvR - View Document
	AIDS Research and Therapy BioMed Central Open Access DocID: 1602b - View Document
	Kwartaalbericht 4e kwartaalnovember 2012 Contents DocID: 15RYb - View Document